-
For 5 consecutive years, run 40,000 kilometers "Guangdong good doctor" to help build the first independent county-level rheumatology specialist in western Guangdong.
Time of Update: 2020-10-20
Seafood boss pain risk amputation, fortunately encountered back home to visit his 35-year-old Mr. Chen (analyte) is from Zhanjiang, Guangdong Province, October 4, he once again came to Wuchuan City People's Hospital rheumatology immunology department, met to visit the Second People's Hospital of Guangdong Province (hereinafter referred to as "provincial second doctor") rheummatology immunology department director, chief physician Li Tianwang.
-
5 reasons to get a flu shot - especially this year!
Time of Update: 2020-10-15
September 29, 2020 // -- What happens when COVID-19 and influenza become both endemic in the United States this fall? We all don't know, and wearing masks, washing our hands, and keeping distance from
-
World Heart Day, September 29 Focus on heart health! These research results are worth reading!
Time of Update: 2020-10-15
28, 2020 is the 21st World Heart Day, this year's World Heart Day activity theme is "USE TO BEAT", in this article, the small compilation of a number of important research results to focus on the imp
-
4th adaptive! Pfizer Xeljanz approved by FDA as the first JAK inhibitor for the treatment of early-onset idiolytic arthritis (JIA)!
Time of Update: 2020-10-15
September 29, 2020 // -- Pfizer (Pfizer) recently announced that the U.S. Food and Drug Administration (FDA) has approved Xeljanz (Tofacitinib, Tofatinib) for the treatment of active polyarthritis (PCJIA) in children and adolescents as young as ≥2 years of age.
-
New drug for hereditary angioedema (HAE)! FDA approves Haegarda: used to routinely prevent HAE ≥ 6-year-old patients in the united states.
Time of Update: 2020-10-15
recently, the company announced that the U.S. Food and Drug Administration (FDA) has approved Haegarda (subsurfic injection type C1 esterase inhibitor, C1-INH) expanded adaptation as a conventional preventive treatment for patients 6 years of age and older to prevent hereditary angioedema (HAE) episodes.
-
Nat Commun: Multiple sclerosis drugs can be used to treat coronavirus infections.
Time of Update: 2020-10-14
a study led by Christian Kanstrup Holm and David Olagnier showed that a drug called fumarate methamphetide (DMF), approved for the treatment of multiple sclerosis patients, inhibits the growth of a range of viruses in human cells, including coronavirus (SARS-CoV2).
-
Inter Immunopharma: Artificial intelligence helps predict the accuracy of COVID-19 diagnostics.
Time of Update: 2020-10-14
Oct 7, 2020 /--- In a recent study, researchers developed artificial intelligence (AI) technology that accurately predicts COVID-19 infections through standard blood tests.
(bioon.com) Source: Researchers developed intelligence for early prediction of COVID-19 from standard blood tests Source: Abhirup Banerjee et al.
-
PLoS Comput Biol: Genetic barcodes reveal the evolutionary path of the new coronavirus.
Time of Update: 2020-10-14
4, 2020 /--- In a recent study, researchers at Drexel University reported a way to quickly identify and label mutations in COVID-19 viruses.
, a tool called ISM, is particularly useful because it does not require analysis of the virus's complete genetic sequence to identify its mutations.
-
Progress on HIV research in September 2020.
Time of Update: 2020-10-14
An antibiotic molecule that allows the immune system to kill HIV-infected human cells doi:10.1073/pnas.2008615117 In a new study, Mark Painter, Dr. Kathleen Collins of the University of Michigan School of Medicine, and colleagues work together to find a weapon to kill HIV by targeting a protein called Nef.
-
Nat Cell Biol: New paths help repair lung tissue.
Time of Update: 2020-10-14
"Using techniques including genome-wide and single-cell analysis, we have identified specific cellular pathways involved in lung tissue regeneration and have identified drugs that target that pathway," said senior author G.
-
NEJM: Phase III clinical trials have shown that Artju monoantigen significantly prolongs the survival of non-small cell lung cancer patients who express PD-L1.
Time of Update: 2020-10-14
Oct 6, 2020 /--- According to a new clinical trial, for patients with non-small cell lung cancer (NSCLC) that expresses PD-L1, atezolizumab treatment can lead to a longer total lifetime than chemotherapy.
-
The COVID-19 quick detection shows a high degree of sensitivity.
Time of Update: 2020-10-14
Suchhan de Silva, of the Department of Infection, Immunology and Cardiovascular Disease at the University of Sheffield, said: "These preliminary but promising data suggest that LamPORE has the potential to expand the type and scale of SARS-CoV-2 testing.
-
Front Immunol: Targeted stem cells can be used to regulate inflammatory responses.
Time of Update: 2020-10-14
but in a new study recently published in the journal Frontiers in Immunology, scientists have found that a specific type of molecule may stimulate stem cell regeneration, reversing inflammation caused by periodontical disease.
-
Scientists' new achievements in cancer recurrence research!
Time of Update: 2020-10-14
Doi:10.1038/s41590-020-0733-2 In a recent study published in the international journal Nature Immunology, scientists from the University of Pittsburgh and other institutions found that by blocking "immune memory checkpoints" identified in immune cells, or improving immunotherapy and helping to prevent cancer recurrence.
-
Science Sub-Journal: Revealing the Role of Monocytes in COVID-19.
Time of Update: 2020-10-14
September 30, 2020 /--- In a new study, researchers from research institutions such as the University of Manchester in the United Kingdom have found that monocytes (a type of white blood cell) released from bone marrow to the blood have abnormal characteristics in people with COVID-19, and are more severe in patients with severe infections.
-
Nat Immunol: Cell suicide can help the immune system cope with viral infections.
Time of Update: 2020-10-14
these findings suggest that neophils play an important alcidal role, benefiting other immune cells by providing critical resources for survival and in the process enhancing the body's immune response to the virus.
-
How can those "god medicines" in clinical studies help improve human health?
Time of Update: 2020-10-14
In the first study, researchers reviewed data on 460 people with head and neck squamous cell carcinoma (HNSCC) or early non-small cell lung cancer (NSCLC) and found that ingesting nonsteroidal anti-inflammatory drugs, such as low-dose aspirin, along with standard radiotherapy or chemotherapy, increased survival rates for these cancer patients by 8 percent.
-
Redox Biol: Nitric oxide can be used to treat COVID-19.
Time of Update: 2020-10-14
"As far as we know, nitric oxide is the only substance that has so far been shown to have a direct impact on SARS-CoV-2," said Mike Lundkvist, a professor at Uppsala University who led the study.
-
STM: What are the causes of brain infections in Ugandan children?
Time of Update: 2020-10-14
(Photo Source: Schiff Lab, Penn State) According to a recent paper published in the journal Science Translational Medicine, the National Institutes of Health discovered the main bacteria and viruses of these infections in a five-year study in Uganda using advanced genomics techniques.
-
Science Sub-Journal: Reveals that OVERactivation of MAIT cells is associated with severe COVID-19.
Time of Update: 2020-10-14
their results showed a sharp decline in the number of MAIT cells in the blood of moderate or severe COVID-19 patients, while the remaining circulating MAIT cells were highly activated, indicating that they were involved in an immune response to SARS-CoV-2.
